Veteran private markets professional focusing on growth-stage and middle-market investments across healthcare, financial services and business services. Christian J. Cyr is an investor and operator with a background in corporate finance, M&A and portfolio company value creation. Experience includes sourcing deal flow, leading diligence, executing carve-outs and active board oversight. Investment approach emphasizes operational improvements, revenue growth and disciplined capital-structure management. Frequently serves as chair or board director for portfolio companies and partners with limited partners and co-investors on buy-and-build and growth equity situations.
Veteran private markets professional focusing on growth-stage and middle-market investments across healthcare, financial services and business services. Christian J. Cyr is an investor and operator with a background in corporate finance, M&A and portfolio company value creation. Experience includes sourcing deal flow, leading diligence, executing carve-outs and active board oversight. Investment approach emphasizes operational improvements, revenue growth and disciplined capital-structure management. Frequently serves as chair or board director for portfolio companies and partners with limited partners and co-investors on buy-and-build and growth equity situations.
Focuses on growth-stage and middle-market opportunities in healthcare, financial services and business services, combining investor rigor with operator-led value creation. Prioritizes carve-outs, buy-and-build and growth equity situations where hands-on board oversight and active portfolio management can drive operational improvements and revenue expansion. Underwrites deals with disciplined capital-structure thinking, detailed commercial and execution diligence, and a medium-to-long time horizon. Prefers partnerships with LPs and co-investors to deploy patient capital and accelerate scale through targeted M&A and commercial initiatives.
Focuses on growth-stage and middle-market opportunities in healthcare, financial services and business services, combining investor rigor with operator-led value creation. Prioritizes carve-outs, buy-and-build and growth equity situations where hands-on board oversight and active portfolio management can drive operational improvements and revenue expansion. Underwrites deals with disciplined capital-structure thinking, detailed commercial and execution diligence, and a medium-to-long time horizon. Prefers partnerships with LPs and co-investors to deploy patient capital and accelerate scale through targeted M&A and commercial initiatives.
| Trades 414 | Longs Won 282/414 68% | Profit Factor 8.45 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $249,164.64 |
| Average Win $100,908.98 | Best Trade (Jul 16) $2.3M | Sharpe Ratio -11.27 |
| Average Loss -$25,519.52 | Worst Trade (Dec 31) -$414,755.51 | Z-Score 4.27 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w 2d | Expectancy $60,598.44 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,092 | 6,383 | 5,674 | 4,965 | 4,255 | 3,546 | 2,837 | 2,128 | 1,418 | 709 |